Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.35% |
| 2 | Energy | 10.93% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Financials | 8.18% |
| 5 | Technology | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Titan Machinery
TITN
$469M
| $157K | ﹤0.01% |
13,654
-7,935
| -37% | -$108K |
|
|
GSOL
3177
DELISTED
Global Sources Ltd
GSOL
| $157K | ﹤0.01% |
18,896
-23,058
| -55% | -$182K |
|
3178
Crocs
CROX
$6.69B
| $154K | ﹤0.01% |
11,949
-19,392
| -62% | -$281K |
|
|
MSL
3179
DELISTED
Midsouth Bancorp, Inc.
MSL
| $154K | ﹤0.01% |
13,152
-1,997
| -13% | -$27.5K |
|
3180
Eledon Pharmaceuticals
ELDN
$276M
| $153K | ﹤0.01% |
+91
| New | +$187K |
|
|
PCOM
3181
DELISTED
Points.com Inc. Common Shares
PCOM
| $153K | ﹤0.01% |
14,065
-15,771
| -53% | -$165K |
|
|
REMY
3182
DELISTED
REMY INTL INC NEW COMMON
REMY
| $153K | ﹤0.01% |
5,230
-51,229
| -91% | -$1.46M |
|
3183
Milestone Scientific
MLSS
$35.6M
| $152K | ﹤0.01% |
+49,625
| New | +$152K |
|
3184
Nature's Sunshine
NATR
$362M
| $152K | ﹤0.01% |
+12,688
| New | +$158K |
|
|
EVOK
3185
DELISTED
Evoke Pharma
EVOK
| $150K | ﹤0.01% |
+357
| New | +$224K |
|
|
FRED
3186
DELISTED
Fred's Inc
FRED
| $150K | ﹤0.01% |
+12,700
| New | +$195K |
|
|
CTLP
3187
DELISTED
Cantaloupe
CTLP
| $149K | ﹤0.01% |
59,965
-830,570
| -93% | -$2.59M |
|
3188
VanEck Energy Income ETF
EINC
$77.6M
| $148K | ﹤0.01% |
+1,427
| New | +$184K |
|
|
LF
3189
DELISTED
LEAPFROG ENTERPRISES INC.
LF
| $148K | ﹤0.01% |
206,942
+58,568
| +39% | +$61.1K |
|
|
GLBR
3190
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
| $147K | ﹤0.01% |
16,862
-32,326
| -66% | -$334K |
|
|
AMFW
3191
DELISTED
AMEC Foster Wheeler plc
AMFW
| $147K | ﹤0.01% |
+13,521
| New | +$166K |
|
3192
Xcel Brands
XELB
$7.69M
| $146K | ﹤0.01% |
+1,700
| New | +$149K |
|
|
PGN
3193
DELISTED
PARAGON OFFSHORE PLC (GBR)
PGN
| $145K | ﹤0.01% |
603,800
-369,274
| -38% | -$251K |
|
|
SVA
3194
DELISTED
Sinovac Biotech, Ltd
SVA
| $145K | ﹤0.01% |
+28,500
| New | +$151K |
|
|
PRMW
3195
DELISTED
Primo Water Corporation
PRMW
| $145K | ﹤0.01% |
+19,257
| New | +$123K |
|
3196
DNP Select Income Fund
DNP
$4.15B
| $144K | ﹤0.01% |
+16,076
| New | +$159K |
|
3197
Arcturus Therapeutics
ARCT
$164M
| $142K | ﹤0.01% |
+3,354
| New | +$176K |
|
3198
KVH Industries
KVHI
$181M
| $141K | ﹤0.01% |
14,112
-28,255
| -67% | -$322K |
|
3199
Meritage Homes
MTH
$4.89B
| $141K | ﹤0.01% |
+7,736
| New | +$166K |
|
3200
Abeona Therapeutics
ABEO
$349M
| $139K | ﹤0.01% |
1,371
-349
| -20% | -$46.3K |
|
Similar funds
Millennium Management's Q3 2015 Portfolio in Review
As of Q3 2015, Millennium Management held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Millennium Management deployed $5.12B of net new capital in Q3 2015, opening 840 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 14% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Millennium Management's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Millennium Management added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Millennium Management's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Millennium Management fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Millennium Management's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Millennium Management opened 840 new positions and closed 681 in Q3 2015.
- Millennium Management's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.